These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Therapy for Graves' ophthalmopathy]. Zheng J, Zhang X, Gong R, Wang J, Tan T. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):876-9. PubMed ID: 15553880 [Abstract] [Full Text] [Related]
7. The use of drugs in the management of Graves' ophthalmopathy. A survey. Usadel KH. Dev Ophthalmol; 1989 Oct; 20():79-85. PubMed ID: 2687055 [No Abstract] [Full Text] [Related]
13. An informative case of Graves' disease with implications for schizophrenia. Adams DD, Knight JG, Manning P, Smith G. J Clin Lab Immunol; 2005 Sep; 53():13-25. PubMed ID: 16805322 [Abstract] [Full Text] [Related]
14. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. Aktaran S, Akarsu E, Erbağci I, Araz M, Okumuş S, Kartal M. Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639 [Abstract] [Full Text] [Related]
15. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy. Boboridis KG, Konstas AG, Krassas GE, Georgiadis NS. Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772 [Abstract] [Full Text] [Related]
16. Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity. Zang S, Ponto KA, Kahaly GJ. J Clin Endocrinol Metab; 2011 Feb; 96(2):320-32. PubMed ID: 21239515 [Abstract] [Full Text] [Related]
19. An update on medical management of Graves' ophthalmopathy. Bartalena L, Marcocci C, Tanda ML, Piantanida E, Lai A, Marinò M, Pinchera A. J Endocrinol Invest; 2005 May; 28(5):469-78. PubMed ID: 16075933 [Abstract] [Full Text] [Related]
20. [Graves' orbitopathy]. Balázs C. Orv Hetil; 2006 Jun 04; 147(22):1011-7. PubMed ID: 16913090 [Abstract] [Full Text] [Related] Page: [Next] [New Search]